INVESTIGATION Of the ProSpace™ Balloon System Pivotal Study BP-007

Clinical Trial Title

INVESTIGATION Of the ProSpace™ Balloon System Pivotal Study BP-007

National Clinical Trial Number:


Clinical Trial Protocol Description:

The purpose of this study is to assess the ability of the ProSpace Balloon to reduce the radiation dose delivered to the anterior rectum. Currently, there are several options for treating prostate cancer, including active surveillance, prostatectomy (surgical removal of all or part of the prostate) and several types of radiation therapy. Your doctor believes that your prostate cancer should receive a form of radiation therapy called Intensity-modulated radiation therapy (IMRT).

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Are at least 18 years of age.
  • Have been histologically diagnosed with invasive adenocarcinoma of the prostate.
  • Are scheduled for radiation therapy (XRT) for prostate cancer by means of IMRT.
  • Are willing to adhere to the follow-up schedule and protocol requirements.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Study Details

Clinical Trial Investigator

Dian Wang, MD

Contact Information

Rush Cancer Center Clinical Trials Office